Arne Søraas

1.3k total citations
31 papers, 704 citations indexed

About

Arne Søraas is a scholar working on Molecular Biology, Neurology and Molecular Medicine. According to data from OpenAlex, Arne Søraas has authored 31 papers receiving a total of 704 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Neurology and 7 papers in Molecular Medicine. Recurrent topics in Arne Søraas's work include Antibiotic Resistance in Bacteria (7 papers), Long-Term Effects of COVID-19 (7 papers) and COVID-19 and Mental Health (5 papers). Arne Søraas is often cited by papers focused on Antibiotic Resistance in Bacteria (7 papers), Long-Term Effects of COVID-19 (7 papers) and COVID-19 and Mental Health (5 papers). Arne Søraas collaborates with scholars based in Norway, United States and South Africa. Arne Søraas's co-authors include Pål A. Jenum, Arnfinn Sundsfjord, Irene Sandven, Cathrine Brunborg, Silje Bakken Jørgensen, Truls Michael Leegaard, Karl Trygve Kalleberg, Knut Liestøl, John Arne Dahl and Merete Ellingjord‐Dale and has published in prestigious journals such as PLoS ONE, Scientific Reports and BMJ.

In The Last Decade

Arne Søraas

29 papers receiving 685 citations

Peers

Countries citing papers authored by Arne Søraas

Since Specialization

Citations

This map shows the geographic impact of Arne Søraas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arne Søraas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arne Søraas more than expected).

Fields of papers citing papers by Arne Søraas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arne Søraas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arne Søraas. The network helps show where Arne Søraas may publish in the future.

Co-authorship network of co-authors of Arne Søraas

This figure shows the co-authorship network connecting the top 25 collaborators of Arne Søraas. A scholar is included among the top collaborators of Arne Søraas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arne Søraas. Arne Søraas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Excess all-cause mortality in Norway in 2024 2025 ·Scandinavian Journal of Public Health ·Richard White, Anders Benteson Nygaard, Arne Søraas, Gunhild Alvik Nyborg	0
2	Epigenetic aging of human blood cells is influenced by the age of the host body 2024 ·Aging Cell ·Petter Holland, (unknown), (unknown), Tobias Gedde‐Dahl, Jochen Buechner, Mari Wildhagen, (unknown), Steve Horvath, Shigemi Matsuyama, John Arne Dahl, Friedrich Stölzel, Arne Søraas	3
3	Executive deficits after SARS-CoV-2 infection: A cross-sectional population study 2024 ·Brain Behavior & Immunity - Health ·(unknown), (unknown), Arne Søraas, Richard White, Ragnhild Bø, (unknown), (unknown), (unknown), Anners Lerdal, Nils Inge Landrø, Anders Benteson Nygaard, Jan Stubberud	0
4	Temporal trajectories of long-COVID symptoms in adults with 22 months follow-up in a prospective cohort study in Norway 2024 ·International Journal of Infectious Diseases ·(unknown), Anders Benteson Nygaard, Nathalie C. Støer, Ragnhild Bø, Nils Inge Landrø, (unknown), (unknown), Karl Trygve Kalleberg, John Arne Dahl, Linda N. Geng, (unknown), Elio Ríboli, Giske Ursin, Arne Søraas	1
5	Prevalent and immunodominant CD8 T cell epitopes are conserved in SARS-CoV-2 variants 2023 ·Cell Reports ·Saskia Meyer, (unknown), Ravi Chand Bollineni, (unknown), Trung Tran, Cathrine Knetter, Ke‐Zheng Dai, Torfinn Støve Madssen, John Torgils Vaage, (unknown), Weiwen Yang, Lise Sofie Haug Nissen‐Meyer, (unknown), Maarja Laos, Morten M. Nielsen, Bernd Thiede, Arne Søraas, Fridtjof Lund‐Johansen, Even H Rustad, Johanna Olweus	20
6	DNase analysed by a novel competitive assay in patients with complications after ChAdOx1 nCoV‐19 vaccination and in normal unvaccinated blood donors 2023 ·Scandinavian Journal of Immunology ·Magne K. Fagerhol, Nina Haagenrud Schultz, Mohammad Reza Mirlashari, Markus Wiedmann, Lise Sofie Haug Nissen‐Meyer, Arne Søraas, Geir Hetland	1
7	Prevention of covid-19 and other acute respiratory infections with cod liver oil supplementation, a low dose vitamin D supplement: quadruple blinded, randomised placebo controlled trial 2022 ·BMJ ·(unknown), Anders Benteson Nygaard, (unknown), Petter Holland, (unknown), Karl Trygve Kalleberg, Camilla Lund Søraas, Kirsten B. Holven, Stine M. Ulven, Anette Hjartåker, Trond Haider, Fridtjof Lund‐Johansen, John Arne Dahl, Helmut E. Meyer, Arne Søraas	40
8	Post-acute symptoms 3-15 months after COVID-19 among unvaccinated and vaccinated individuals with a breakthrough infection 2022 ·International Journal of Infectious Diseases ·(unknown), Anders Benteson Nygaard, Morten Wang Fagerland, Petter Holland, (unknown), John Arne Dahl, Arne Søraas	17
9	EWAS of post-COVID-19 patients shows methylation differences in the immune-response associated gene, IFI44L, three months after COVID-19 infection 2022 ·Scientific Reports ·Yunsung Lee, (unknown), Karl Trygve Kalleberg, (unknown), Andreas Lind, Fridtjof Lund‐Johansen, (unknown), Arne Søraas, Jennifer R. Harris, John Arne Dahl, (unknown), Astanand Jugessur	17
10	Cri du chat syndrome patients have DNA methylation changes in genes linked to symptoms of the disease 2022 ·Clinical Epigenetics ·Petter Holland, Mari Wildhagen, (unknown), (unknown), John Arne Dahl, Arne Søraas	9
11	Cognitive rehabilitation in post-COVID-19 condition: A study protocol for a randomized controlled trial 2022 ·Contemporary Clinical Trials ·(unknown), Anners Lerdal, Arne Søraas, Nils Inge Landrø, Ragnhild Bø, Milada Cvancarova Småstuen, Jacqueline Becker, Jan Stubberud	6
12	Vaccine associated benign headache and cutaneous hemorrhage after ChAdOx1 nCoV-19 vaccine: A cohort study 2022 ·Journal of Stroke and Cerebrovascular Diseases ·Nina Haagenrud Schultz, Arne Søraas, Ingvild Hausberg Sørvoll, Çiğdem Akalın Akkök, (unknown), (unknown), Maria Therese Ahlén, Pål André Holme, Anne Hege Aamodt, Karolina Skagen, Thor Håkon Skattør, Mona Skjelland, (unknown)	2
13	The use of public transport and contraction of SARS-CoV-2 in a large prospective cohort in Norway 2022 ·BMC Infectious Diseases ·Merete Ellingjord‐Dale, Karl Trygve Kalleberg, (unknown), Anders Benteson Nygaard, (unknown), (unknown), John Arne Dahl, Eyrun Floerecke Kjetland, Giske Ursin, Arne Søraas	7
14	Dispersion of SARS‐CoV‐2 in air surrounding COVID‐19‐infected individuals with mild symptoms 2022 ·Indoor Air ·Jostein Gohli, (unknown), Arne Broch Brantsæter, (unknown), (unknown), (unknown), Andreas Lind, (unknown), Arne Søraas, Marius Dybwad	4
15	Persisting symptoms three to eight months after non-hospitalized COVID-19, a prospective cohort study 2021 ·PLoS ONE ·Arne Søraas, Karl Trygve Kalleberg, John Arne Dahl, Camilla Lund Søraas, Tor Åge Myklebust, (unknown), Andreas Lind, (unknown), Silje Bakken Jørgensen, (unknown), Eyrun Floerecke Kjetland, Giske Ursin	32
16	Epigenetic age is a cell‐intrinsic property in transplanted human hematopoietic cells 2019 ·Aging Cell ·Arne Søraas, Mieko Matsuyama, Marcos de Lima, David N. Wald, Jochen Buechner, Tobias Gedde‐Dahl, Camilla Lund Søraas, Brian Chen, Luigi Ferrucci, John Arne Dahl, Steve Horvath, Shigemi Matsuyama	35
17	Fecal carriage of extended spectrum β-lactamase producing Escherichia coli and Klebsiella pneumoniae after urinary tract infection – A three year prospective cohort study 2017 ·PLoS ONE ·Silje Bakken Jørgensen, Arne Søraas, Arnfinn Sundsfjord, Knut Liestøl, Truls Michael Leegaard, Pål A. Jenum	38
18	A comparison of extended spectrum β-lactamase producing Escherichia coli from clinical, recreational water and wastewater samples associated in time and location 2017 ·PLoS ONE ·Silje Bakken Jørgensen, Arne Søraas, (unknown), Truls Michael Leegaard, Arnfinn Sundsfjord, Pål A. Jenum	71
19	High Rate of Per Oral Mecillinam Treatment Failure in Community-Acquired Urinary Tract Infections Caused by ESBL-Producing Escherichia coli 2014 ·PLoS ONE ·Arne Søraas, Arnfinn Sundsfjord, Silje Bakken Jørgensen, Knut Liestøl, Pål A. Jenum	47
20	Risk Factors for Community-Acquired Urinary Tract Infections Caused by ESBL-Producing Enterobacteriaceae –A Case–Control Study in a Low Prevalence Country 2013 ·PLoS ONE ·Arne Søraas, Arnfinn Sundsfjord, Irene Sandven, Cathrine Brunborg, Pål A. Jenum	183

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact